"Immunoglobulin M" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.
| Descriptor ID |
D007075
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.574 D12.776.124.790.651.114.619.574 D12.776.377.715.548.114.619.574
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin M".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin M".
This graph shows the total number of publications written about "Immunoglobulin M" by people in this website by year, and whether "Immunoglobulin M" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 1 | 9 | 10 |
| 2005 | 0 | 6 | 6 |
| 2006 | 1 | 3 | 4 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 4 | 4 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 5 | 7 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 3 | 4 |
| 2016 | 1 | 8 | 9 |
| 2017 | 25 | 58 | 83 |
| 2018 | 13 | 75 | 88 |
| 2019 | 10 | 23 | 33 |
| 2020 | 47 | 147 | 194 |
| 2021 | 34 | 125 | 159 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin M" by people in Profiles.
-
Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19. J Appl Lab Med. 2022 01 05; 7(1):382-386.
-
New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization. Ann Lab Med. 2022 01 01; 42(1):113-116.
-
Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay. IEEE Trans Nanobioscience. 2022 01; 21(1):37-43.
-
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. J Appl Lab Med. 2021 11 01; 6(6):1561-1570.
-
Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays. Ann Lab Med. 2021 Nov 01; 41(6):577-587.
-
[Distribution and infectious characteristics of re-positive cases infected with SARS-CoV-2]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10; 42(10):1750-1756.
-
A high-throughput microsphere-based immunoassay of anti-SARS-CoV-2 IgM testing for COVID-19 diagnostics. PLoS One. 2021; 16(9):e0248444.
-
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies. Blood. 2021 09 02; 138(9):811-814.
-
Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies. Anal Chem. 2021 09 14; 93(36):12391-12399.
-
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics. Geroscience. 2021 10; 43(5):2249-2264.